Utah Medical Products, Inc. (UTMD)
Company Info
US9174881089
917488108
Mar 8, 1999
Highlights
$200.04M
$3.96
15.15
$31.75M
$18.31M
$13.00M
$59.74 - $76.62
2.74%
3.39
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Utah Medical Products, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Utah Medical Products, Inc. had a return of -2.42% year-to-date (YTD) and -17.65% in the last 12 months. Over the past 10 years, Utah Medical Products, Inc. had an annualized return of 2.02%, while the S&P 500 had an annualized return of 11.41%, indicating that Utah Medical Products, Inc. did not perform as well as the benchmark.
UTMD
-2.42%
-2.23%
-8.27%
-17.65%
-6.51%
2.02%
^GSPC (Benchmark)
2.66%
1.61%
15.23%
22.15%
12.59%
11.41%
Monthly Returns
The table below presents the monthly returns of UTMD, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -0.39% | -2.42% | |||||||||||
| 2024 | -5.95% | -11.40% | 1.76% | -6.90% | 3.16% | -1.73% | 4.18% | -2.31% | -1.15% | -5.28% | 2.95% | -5.33% | -25.69% |
| 2023 | -8.36% | -0.38% | 3.59% | 0.07% | -1.42% | 0.00% | 5.50% | -6.84% | -5.79% | -7.53% | 6.01% | 0.26% | -15.10% |
| 2022 | -5.93% | -4.32% | 0.16% | -5.86% | 1.83% | 0.07% | 6.33% | 0.61% | -6.86% | 4.97% | -0.55% | 13.23% | 1.87% |
| 2021 | 2.81% | -2.62% | 2.92% | 0.76% | -1.78% | -0.44% | 5.13% | -0.89% | 5.11% | 4.30% | 15.21% | -8.72% | 21.97% |
| 2020 | -14.67% | -5.07% | 7.95% | -11.75% | 19.86% | -10.66% | -8.03% | 0.80% | -2.43% | 3.92% | 4.01% | -2.05% | -20.87% |
| 2019 | 13.07% | -9.64% | 4.31% | -4.36% | -5.51% | 20.40% | -4.92% | 8.06% | -2.25% | 6.92% | 4.25% | 1.28% | 31.46% |
| 2018 | 10.69% | -1.55% | 11.77% | 2.73% | 3.05% | 5.53% | -11.94% | -6.34% | 3.98% | -7.45% | 8.84% | -12.17% | 3.24% |
| 2017 | -14.50% | -0.48% | 1.08% | 0.48% | 7.35% | 8.15% | -4.56% | 4.41% | 2.31% | 2.52% | 8.29% | 0.03% | 13.59% |
| 2016 | -3.71% | 5.11% | 6.01% | 6.97% | -2.18% | -3.34% | 3.29% | -3.17% | -4.70% | 3.93% | 9.73% | 7.08% | 26.32% |
| 2015 | -5.60% | 4.78% | 1.21% | -9.94% | 1.52% | 9.44% | -8.32% | -2.34% | 1.39% | 9.47% | -4.21% | 4.11% | -0.71% |
| 2014 | -6.93% | 3.36% | 5.64% | -12.17% | 7.91% | -5.70% | 1.11% | 0.15% | -5.93% | 16.49% | 2.24% | 3.88% | 7.04% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of UTMD is 7, meaning it’s performing worse than 93% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Utah Medical Products, Inc. (UTMD) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Utah Medical Products, Inc. provided a 2.01% dividend yield over the last twelve months, with an annual payout of $1.21 per share. The company has been increasing its dividends for 2 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $1.21 | $1.21 | $1.19 | $1.17 | $2.86 | $1.13 | $1.11 | $1.09 | $1.07 | $1.05 | $1.03 | $1.01 |
Dividend yield | 2.01% | 1.96% | 1.41% | 1.16% | 2.86% | 1.33% | 1.02% | 1.31% | 1.31% | 1.44% | 1.75% | 1.67% |
Monthly Dividends
The table displays the monthly dividend distributions for Utah Medical Products, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | ||||||||||
| 2024 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.31 | $1.21 |
| 2023 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.30 | $1.19 |
| 2022 | $0.00 | $0.00 | $0.29 | $0.00 | $0.00 | $0.29 | $0.00 | $0.00 | $0.29 | $0.00 | $0.00 | $0.30 | $1.17 |
| 2021 | $0.00 | $0.00 | $0.29 | $0.00 | $0.00 | $0.29 | $0.00 | $0.00 | $0.29 | $0.00 | $0.00 | $2.00 | $2.86 |
| 2020 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.29 | $1.13 |
| 2019 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.28 | $1.11 |
| 2018 | $0.00 | $0.00 | $0.27 | $0.00 | $0.00 | $0.27 | $0.00 | $0.00 | $0.27 | $0.00 | $0.00 | $0.28 | $1.09 |
| 2017 | $0.00 | $0.00 | $0.27 | $0.00 | $0.00 | $0.27 | $0.00 | $0.00 | $0.27 | $0.00 | $0.00 | $0.27 | $1.07 |
| 2016 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.27 | $1.05 |
| 2015 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.26 | $1.03 |
| 2014 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.26 | $1.01 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Utah Medical Products, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Utah Medical Products, Inc. was 48.84%, occurring on Feb 3, 2025. The portfolio has not yet recovered.
The current Utah Medical Products, Inc. drawdown is 48.79%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -48.84% | Nov 23, 2021 | 801 | Feb 3, 2025 | — | — | — |
| -36.07% | Aug 4, 2004 | 8 | Aug 13, 2004 | 302 | Oct 24, 2005 | 310 |
| -35.27% | Jun 21, 2018 | 129 | Dec 24, 2018 | 732 | Nov 18, 2021 | 861 |
| -35.16% | Mar 26, 2007 | 430 | Dec 29, 2008 | 732 | Jan 10, 2012 | 1162 |
| -28.68% | Aug 2, 2001 | 32 | Sep 21, 2001 | 78 | Jan 15, 2002 | 110 |
Volatility
Volatility Chart
The current Utah Medical Products, Inc. volatility is 5.49%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Utah Medical Products, Inc. compared to its peers in the Medical Instruments & Supplies industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for UTMD in comparison to other companies of the Medical Instruments & Supplies industry. Currently, UTMD has a PE value of 15.1. This PE value is considered to be low compared to the rest of the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for UTMD in comparison to other companies of the Medical Instruments & Supplies industry. Currently, UTMD has a PEG value of 0.0. This PEG ratio falls in the average range for the industry.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Utah Medical Products, Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |